The company has a Board of Directors consisting of 9 members, including 3 independent directors, with a term of three years. Currently, two female directors are serving on the Board. Directors are elected through a candidate nomination system, with final selection by the shareholders’ meeting from the list of nominated candidates.
The Board convenes at least once every quarter. All directors possess the professional expertise necessary to perform their duties and bring a range of skills in business management, strategic decision-making, industry knowledge, and financial accounting. Directors uphold an impartial and independent spirit, exercising their powers following applicable laws and regulations, the company’s Articles of Incorporation, and resolutions of the shareholders’ meeting. They provide valuable guidance and consultation on the company’s operational strategies, financial planning, and the development of innovative biopharmaceuticals.
Directors continue to receive professional development throughout their term. The company also maintains liability insurance for all directors in connection with the performance of their duties.

Chairman Ming-Tsuen Chen

  • Department of Medicine, Kaohsiung Medical University.
  • Director, Shu-Tien Urological & Ophthalmological Clinic, Shu-Tien Medical Foundation Present Employment
  • CEO, Healthcare Division, RunTai Group

DirectorBasma C. C. Cheng

  • Representative of National Development Fund., Executive Yuan
  • MD, Graduate Institute of Labor Research, National Chengchi University 
  • Deputy Director General of Department of Human Resources Development at the National Development Council

Director Lin Shih Chia

  • Representative of National Devlopment Fund., Executive Yuan
  • Institute of Health and Welfare Policy, National Yang-Ming University
  • CEO of Foundation of Medical Professionals Alliance in Taiwan
  • General Manager, TaiAn Technologies Corp

DirectorJimmy Chang, Ph.D.

  • Ph.D. of Pharmaceutics, University of Texas at Austin. USA
  • Former Executive Director at Allergan Inc.
  • CEO of TaiMed Biologics Inc.

Director Tamon Tseng, LLM.

  • Mr. Tseng joined Ruentex Group in 1992, and is currently serving as Special Assistant to the CEO of Ruentex Industries, Ltd.
  • Mr. Tseng was called to the English Bar in 1985. He received a B.A. from the University of Cambridge, an LL.M. from University College London, and an LL.B. from National Chengchi University.

DirectorFrank Chen

  • Representative of Chang Chun Investment, Ruentex Group
  • Master degree in Business Administration from National Taiwan University
  • Vice General Manager, Investment Management and Special Assistant to Chairman of Ruentex Group

Independent DirectoChiu, Chin-Ting.

  • MBA, National Taiwan University
  • Chairman, Securities and Futures Investors Protection Center
  • Chairman, TAIWAN-CA INC.
  • Member of Mediation Committee, Securities and Futures Investors Protection Cente

Independent DirectorGwo-Fong Lin, Ph.D

  • Doctor of Philosophy in Engineering, University of Pittsburgh
  • Distinguished Professor, National Taiwan University
  • Corresponding Member, International Academy of Engineering, Russia

Independent DirectorHoward S. Lee, Ph.D.

  • PhD in Chemistry, University of Southern California, USA
  • Partner, The CID Group
  • Chairman, Easywell Biomedicals, Inc.
  • Chairman, TAHO Pharmceuticals, Ltd.
  • Chairman, Transwell Biotech CO., Ltd.